Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with LDL-C \>70 mg/dL \& on a stable dose of atorvastatin 40 mg~Exclusion Criteria:~* Pregnant or lactating women or intending to become pregnant~* Patient with sensitivity or intolerance to ezetimibe or atorvastatin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Atorvastatin 80 mg
- 2 (Type: EXPERIMENTAL): Atorvastatin 40 mg + ezetimibe 10 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).